Detalles de la búsqueda
1.
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents.
Blood
; 141(3): 219-230, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36095849
2.
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Haematologica
; 108(8): 2192-2204, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546453
3.
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
J Immunother Cancer
; 11(5)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137553
4.
Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
Clin Drug Investig
; 42(1): 29-41, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34822128
5.
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 22(9): 690-701, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764490
6.
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 38(10): 1759-1767, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815818
7.
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma.
Leukemia
; 36(5): 1371-1376, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332278
8.
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.
Cancers (Basel)
; 13(23)2021 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34885106
Resultados
1 -
8
de 8
1
Próxima >
>>